âš« Exerts gastro-kinetic effect by enhancing acetylcholine release
âš« Improves upper gastrointestinal motility to relieve abdominal symptoms arising due to impaired GI motility in FD patients
âš« Approved in India in 2016 for the treatment of bloating after meals, epigastric bloating and early satiety in FD patients
âš« Has the potential to be a promising gastroprokinetic agent for FD because of its efficacy without any significant adverse events